Unveiling a novel role for p19Arf (alternative reading frame) in mESC differentiation toward the pancreatic lineage
De Marino Elena, Napolitano Giuliana, Roscigno Giuseppina, Lucci Valeria, Falco Geppino, Calabrò Viola, Vivo Maria, Angrisano Tiziana, Antonini Dario, Pollice Alessandra · 2026
Read Unveiling a novel role for p19Arf (alternative reading frame) in mESC differentiation toward the pancreatic lineage by De Marino Elena, Napolitano Giuliana, Roscigno Giuseppina, Lucci Valeria, Falco Geppino, Calabrò Viola, Vivo Maria, Angrisano Tiziana, Antonini Dario, Pollice Alessandra (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13439060.txt.
Description
De Marino Elena's team uncovered a new role in 2026 for p19Arf, a mouse tumor suppressor, in steering stem cells toward pancreatic fate. ARF is famed for tumor surveillance, but its wider jobs were still emerging. Mouse embryonic stem cells with CRISPR mutations in p19Arf were driven toward pancreatic endoderm, with gene networks, cell shape, and architecture tracked.
Mutant cells failed to differentiate efficiently into pancreatic endoderm, gene networks for lineage, skeleton, and shape shifted, and cell architecture broke down, with partial loss leaving pluripotency traits lingering. Developmental biologists get evidence that a cancer guardian also guides early pancreas fate. The work reframes ARF as a differentiation regulator, not only a tumor guard.
Catalog record
| CREATOR | De Marino Elena, Napolitano Giuliana, Roscigno Giuseppina, Lucci Valeria, Falco Geppino, Calabrò Viola, Vivo Maria, Angrisano Tiziana, Antonini Dario, Pollice Alessandra |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |